US-based digital health startup Cohero Health has closed a $9m series A round that featured Zaffre Investments, the strategic investment arm of health insurance provider Blue Cross Blue Shield of Massachusetts.
Three Leaf Ventures, an affiliate of investment firm Broe Group, led the round, which included manufacturing conglomerate Heitkamp & Thumann and GIS Strategic Ventures, the corporate venturing unit of insurance company Guardian Life Insurance, as well as BioAdvance and P5 Health Ventures.
Cohero has created a platform dubbed BreatheSmart which tracks medication adherence and measures lung functions of patients suffering from respiratory conditions. The patients are kept engaged through mobile apps, custom reminders and rewards for sticking to a therapy.
The series A proceeds will allow Cohero to further develop BreatheSmart, boost its commercial business development activities and expand its clinical trial program.
Chero previously closed a $2m seed round in December 2015 that featured Zaffre Investments, Three Leaf Ventures, BioAdvance, Swanhill Capital and StartUp Health.
Melissa Manice, co-founder and CEO of Cohero Health, said: “We started Cohero Health with the goal of empowering pulmonary patients to engage in their care. This investment will sustain this mission, transforming respiratory care for patients and the many stakeholders that support the respiratory community.”